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Abstract
The prominence of anxiety disorders in today’s general population is a major public health
concern. Advancing research of the underlying pathophysiology of anxiety disorders can lead to
the discovery of effective treatment interventions to treat the mental and physical symptoms of
anxiety, and thus improve quality of life. This study aimed to examine two brain areas in the
limbic and reward systems, the amygdala and Nucleus Accumbens (NAcc), and the structural
white matter connection between them. This neural circuit assigns affective valence to
environmental stimuli and motivates behavior to avoid potential harm. This study utilized
diffusion Magnetic Resonance Imaging (dMRI) from the longitudinal multi-site Adolescent
Brain Cognitive Development (ABCD) study to investigate the structure of these brain regions
and the coherence of the white matter tract that directly connects them. Results indicated that in
adolescents with clinical anxiety, significantly reduced Fractional Anisotropy (FA; an index of
decreased neuron density, neuronal disorganization, and demyelination) and significantly
reduced volume are observed in the BasoLateral nucleus of the Amygdala (BLA) in both the left
and right hemispheres when compared to controls. This diffusion metric of FA was also found to
be significantly correlated with volume in the BLA of both hemispheres. Additionally, in the
BLA-NAcc tract of the left hemisphere, FA was significantly reduced in the first 25 nodes
nearest the BLA for anxious participants compared to controls. Reduced FA within the BLA was
also found to be significantly correlated with increased anxiety symptom severity. This study
investigated structural differences between anxious and non-anxious adolescents during a period
of maturation in which individuals are at an elevated risk of developing an anxiety disorder. The
ABCD study is ongoing and provides the opportunity for future research to build from this
presented study and investigate how anxiety may induce cognitive changes over time.
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Introduction
Background
Anxiety disorders, including Generalized Anxiety Disorder (GAD), Social Anxiety
Disorder (SAD), Panic Disorder (PD), Specific Phobias (SP), Obsessive-Compulsive Disorder
(OCD), and PostTraumatic Stress Disorder (PTSD), are some of the most prominent psychiatric
disorders afflicting society, affecting individuals of all age ranges and often throughout the life
course unless treatment/intervention is received. The National Alliance on Mental Illness
estimates that approximately 19% of adults in the United States and 7% of children and
adolescents in the United States suffer from some form of an anxiety disorder (2017). Anxiety
disorders are of particular concern because individuals often receive comorbid diagnoses of the
aforementioned anxiety disorders (Burkhouse et al., 2020). Additionally, children and
adolescents are in the “highest risk period for developing an anxiety disorder,” which is an
important consideration when choosing samples for investigation into anxiety pathophysiology
(Burkhouse et al., 2020).
Generalized Anxiety Disorder (GAD) is typically described as fear, distress, worry, and
avoidance that is “excessive” or greater than what a situation warrants (Shin & Liberzon, 2010).
As for the more specific anxiety disorders, Social Anxiety Disorder (SAD) is described as an
extensive fear of social situations, performances, and embarrassment, often leading to avoidance
of social settings (Shin & Liberzon, 2010). Panic Disorder (PD), marked by spontaneous panic
episodes with severe somatic symptoms, also leads to avoidance of situations the individual feels
may trigger an attack (Rauch et al., 2003). Phobias are directed at an “innocuous stimuli or
situation” that causes amplified fear and anxiety in an individual and includes avoidance of the
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phobia’s focus (Rauch et al., 2003). Obsessive-Compulsive Disorder (OCD) is marked by
obsessive, intrusive thoughts in which the individual completes compulsions (ritualistic tasks) in
an attempt to ease the thoughts (Shin & Liberzon, 2010). PostTraumatic Stress Disorder (PTSD)
is characterized by intense hyperarousal and recollections of a specific event that was
traumatizing to the individual; individuals with PTSD will often exhibit avoidance of triggers as
not to be reminded of their trauma (Shin & Liberzon 2010).
Past Research
As anxiety disorders are ubiquitous, several neuroimaging studies have been conducted
utilizing technology including functional (fMRI) and diffusion Magnetic Resonance Imaging (or
Diffusion Tensor Imaging, DTI), as well as Positron Emission Tomography (PET), in an attempt
to understand the specific brain regions and circuitry involved in and impacted by anxiety
disorders. The amygdala’s implication in anxiety disorders is noted early on in past literature due
to its involvement in processing fear stimuli. The amygdala processes fear stimuli by assigning
sensory input with an “emotional value,” accomplished by the “formation of associations
between neutral predictive stimuli and outcomes of positive or negative valence” (Calhoon &
Tye, 2015). Projections from the BLA will then activate either “fear or reward pathways”
depending on the “valence of these cues” (Calhoon & Tye, 2015). Early fMRI studies, as
described in the review by Rauch et al., exhibited the involvement of the amygdala in the
processing of fear and anxiety-provoking stimuli; participants were presented with fearful human
faces or “emotionally valenced” images, and increased amygdala activation (far more significant
than amygdala activation after the presentation of a neutral/happy face or image) was observed
(2003). One PET study, described by Rauch et al., also measured amygdala activation by
utilizing classical conditioning; participants learned to associate a shock (Unconditioned
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Stimulus; US) with a video of a snake (Conditioned Stimulus; CS) and regional Cerebral Blood
Flow (rCBF) changes in the amygdala were monitored upon stimuli presentation (2003). The
study revealed that increased rCBF in the amygdala was correlated with “electrodermal activity
changes,” indicative of an anxious somatic state (Rauch et al., 2003). A PTSD-focused study
discovered amygdala hyperresponsivity as central to PTSD pathophysiology; participants with
PTSD (versus those with trauma exposure without clinical PTSD) experienced significantly
greater amygdala activation, which was revealed through fMRI imaging, after being provoked by
a reminder of their trauma (Rauch et al., 2003). In a PET study of individuals with SAD,
participants were involved in a public speaking experiment and results indicated increased rCBF
in the amygdala for individuals diagnosed with a social anxiety disorder (Rauch et al., 2003).
Anxiety studies have also looked into volumetric and morphometric differences of
Regions-Of-Interest (ROI); for example, “one large mMRI study found reduced orbitofrontal
cortical and amygdala volumes in OCD vs. healthy control subjects” (Rauch et al., 2003). The
review and study by Burkhouse et al. discusses that individuals with GAD, PD, PTSD, and SAD
have been shown to possess a “decreased amygdala volume across youth and adult samples,”
revealed through past morphometric studies, and suggest that this volume reduction is likely due
to “glutamatergic excitotoxicity” from the amygdala hyperactivity that is characteristic of anxiety
disorders (2020). For their adult study, it was also discovered through statistical analyses that
“greater baseline anxiety severity was associated with reduced left amygdala volume”
(Burkhouse et al., 2020). Additional adult studies described by Burkhouse et al. have shown that
anxiety symptom severity “is associated with larger NAcc volume across adults;” the Burkhouse
et al. study replicated this finding and discovered that this morphometric abnormality was
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indicative of a more positive response to anxiety treatment (cognitive behavioral
therapy/selective serotonin reuptake inhibitor administration) post-study (2020).
The Nucleus Accumbens (NAcc), known for its involvement in motivation and reward
processing, is slightly more inconspicuous in anxiety literature compared to other ROIs like the
amygdala; yet, its functions are directly implicated in the avoidance behaviors characteristic of
anxiety disorders. More recent findings, such as the volumetric abnormalities noted by
Burkhouse et al., have highlighted NAcc involvement in the “motivation for avoidance
behaviors” to anxiety-provoking stimuli (2020). The NAcc is involved in responding to aversive
stimuli and then motivating “passive and active avoidance behavior,” which directly corresponds
to the typical behavior of persistent avoidance seen with anxiety disorders (Burkhouse et al.,
2020). Animal literature has demonstrated NAcc involvement in avoidance through NAcc lesion
studies; one study involving an “odor-guided discrimination task” found that the NAcc
“integrates the motivational value of both appetitive and aversive cues” to direct a behavioral
response as the lesioned rats failed to show expected changes in “response latency during
discrimination learning” to the odor indicating the release of a foul-tasting solution (Schoenbaum
& Setlow, 2003). Functional imaging in a study conducted by Levita et al. showed that during
active avoidance of threat (emitting response by pressing a button), the NAcc exhibited increased
activation, and during passive avoidance (omitting response by withholding from pressing the
button), increased deactivation, indicative of NAcc involvement in harm avoidance (2012).
Additionally, the participants' anxiety level at the time of the study was shown to impact the
amount of activation/deactivation seen in the NAcc, with high anxiety correlating to both greater
activation and deactivation for active and passive avoidance, respectively (Levita et al., 2012).
This reveals the importance of considering the NAcc in anxiety pathophysiology and shows that
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the NAcc has involvement in the constancy of avoidance behaviors in individuals with anxiety
disorders (Levita et al., 2012).
The aforementioned studies focused on anxiety and the amygdala and NAcc as individual
ROIs, but a few studies have also looked into the circuitry, or white matter connectivity, that is
believed to play a role in anxiety disorders using diffusion MRI (dMRI). Diffusion MRI is
utilized to predict the orientations of white matter tracts in the brain as water diffusion is “less
hindered parallel than perpendicular to axons” (Jbabdi et al., 2015). dMRI measures “the
diffusion of water molecules in a voxel in the brain from several directions” and uses an
algorithm to generate a “diffusion tensor,” which provides information about metrics like
“fractional anisotropy” in that area (Ayling et al., 2012). Fractional Anisotropy (FA) is the
measure most commonly used in white matter studies to compare the “integrity” of the white
matter connections (Jbabdi et al., 2015). FA is a measure of the “variance of the diffusion
coefficient along all directions in three dimensions under the assumption of anisotropic Gaussian
diffusion,” and can reveal important characteristics of white matter connections such as
myelination/demyelination and density of tracts (Jbabdi et al., 2015). Thus, dMRI relies on the
directionally dependent diffusion of water molecules in the brain and discerns differences in
“neuronal organization” or tract coherence between subjects by allowing for the comparison of
FA values (Ayling et al., 2012). This has been shown in animal models where mice lacking
myelinated axons exhibit lower values of fractional anisotropy (Tisdall et al., 2022). Research on
patient populations with anxiety has utilized a form of dMRI called Diffusion Tensor Imaging
(DTI) and has focused primarily on major white matter tracts at the level of the entire brain. In
the review and adolescent whole-brain white matter study by Liao et al., DTI results showed
“reduced FA in the uncinate fasciculus” (UF), which connects limbic regions, including the
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amygdala, to the PreFrontal Cortex (PFC) and Cingulate Cortex (CC), for adolescents with GAD
(2014). The researchers concluded that this abnormal tract coherence of the UF could be an
explanation for the elevated amygdala activation seen in individuals with anxiety (Liao et al.,
2014). Reduced FA in the UF was also observed in additional studies involving adults diagnosed
with GAD (Liao et al., 2014). The DTI study by Liao et al. also found lower FA values in the
Inferior Longitudinal Fasciculus (ILF) of adolescents with generalized anxiety, which connects
structures including the amygdala and hippocampus, and this was also seen in an external study
in older adults with GAD (2014). The researchers involved in this adolescent study conducted an
additional white matter study in adults that revealed “higher FA in the right amygdala white
matter and lower FA in the caudal anterior cingulate cortex white matter” in individuals with
anxiety (Liao et al., 2014). The Anterior Cingulate Cortex (ACC) is connected to limbic system
regions, including the amygdala and NAcc (Sturm et al., 2016). The finding of higher FA in the
right amygdala is interesting as other white matter studies indicate that they did not find regions
of increased FA in participants with anxiety; however, this study was disadvantaged by an
especially small sample size of only 16 participants. In a DTI study conducted by Wang et al.,
low FA values were seen in the following major white matter “clusters” in psychiatric anxiety
patients: “bilateral uncinate fasciculus, body of corpus callosum, left middle cingulum (cingulate
gyrus), bilateral anterior thalamic radiation and corona radiate, right anterior limb of internal
capsule, bilateral inferior frontal-occipital fasciculus, bilateral superior and inferior longitudinal
fasciculus” (2016). Wang et al. also elucidate that the low FA values of the UF and cingulum
were associated with greater anxiety symptom severity in the patients studied (Wang et al.,
2016). Another DTI study looking specifically at the amygdala-to-PFC connection also stated
that the integrity of this connection is related to reported anxiety levels, explicitly, “higher
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pathway strength predicted lower anxiety,” referring to reported trait anxiety (Kim & Whalen,
2009). The lower FA values observed in these studies can be explained by numerous factors,
including decreased density/myelination of axons, “abnormal axonal membranes,” and
“reorganization of axons at a macroscopic level,” characteristically, disorganization (Lu et al.,
2018). Opposingly, FA values that are higher than normal “are thought to reflect a higher degree
of neuronal organization” (Ayling et al., 2012).
Whereas previous research measured the major long-range white matter tracts of the
whole brain, less research has targeted white matter tracts between two specific brain loci.
Additionally, previous white matter studies of individuals with anxiety disorders have not
focused in on the reward system and its white matter connections, such as the amygdala to NAcc
tract, which has been more recently known to play a role in anxiety disorders in regards to
avoidance behavior. A few studies have taken a functional look at this amyg-NAcc connection;
the study by Levita et al. showed an “increase in functional connectivity between the amygdala
and NAcc” while active avoidance was occurring in individuals with anxiety (2012). Since the
NAcc is an output of the amygdala, the researchers believe that increased amygdala output,
occurring from amygdala hyperresponsivity typical of an anxiety disorder, could explain this
observation (Levita et al., 2012). An animal study involving mice conducted by Beyeler et al.
also took a functional look at the amygdala-NAcc connection by observing the activity of
photo-identified neurons using classical conditioning techniques (2016). The mice were trained
to discriminate between two sounds and associate the sounds with either a positive or negative
outcome; the researchers found that 80% of neurons projecting from the basolateral amygdala to
the NAcc encoded positive valence (i.e., reward) (Beyeler et al., 2016). The involvement of the
NAcc in reward processing is applicable to studies of anxiety disorders, but SAD or social
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phobias are particularly of interest due to the theory of “dysregulated reward” acting as a
cognitive component leading to “social deficits” (Rauch et al., 2003). SAD is reported to be “the
third most common mental health disorder after depression and substance abuse,” and children
and adolescents are of special concern as 90% of individuals with social anxiety experience this
disorder before the age of 23 (Leigh & Clark, 2018).
The previously mentioned ROIs that show volumetric changes in individuals with an
anxiety disorder are “areas where glutamate neurons predominate,” so it is hypothesized that
increased glutamate release is “crucial for structural/functional changes” (Musazzi et al., 2013).
The review by Musazzi et al. elucidates this mechanism of “maladaptive changes” by explaining
that when glutamate transmission is hyperactive, this leads to “building up excessive synaptic or
extrasynaptic levels of glutamate,” which can result in aberrant neuronal remodeling (2013).
Selective Serotonin Reuptake Inhibitors (SSRIs), however, are antidepressants hypothesized to
“exert a protective action when the synapse is overactivated by stress-related mechanisms”
(Musazzi et al., 2013). This theory comes from animal studies, for instance, it has been observed
that the SSRI fluoxetine “reduced depolarization-evoked release of glutamate” in hippocampal
“superfused synaptosomes” (Bonanno et al., 2005). The review by Musazzi et al. also explains
that the association “between dendritic remodeling and volumetric changes is at present
inferential,” which provides an interesting area of future research in anxiety pathophysiology
(2013).
This research project will take a more microscopic look at two ROIs in anxiety
pathophysiology, the amygdala and nucleus accumbens, and their white matter connection at the
structural, rather than functional, level using obtained baseline diffusion MRI data from the
Adolescent Brain Cognitive Development (ABCD) study. This research will utilize the diffusion
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metric of fractional anisotropy to investigate neuronal organization within and between these
ROIs for the following groups of ABCD participants: those with a clinical level of anxiety who
are not on SSRIs, those with a clinical level of anxiety who are on SSRIs, and those who do not
have a clinical level of anxiety and who are not on SSRIs (controls). Due to the findings of the
presented past research studies, and the knowledge that within the reward pathway the amygdala
sends glutamatergic inputs to the NAcc, I hypothesize that the ABCD participants studied with
clinical anxiety will exhibit abnormalities in white matter tract coherence between the amygdala
and NAcc, indicated by decreased FA, and that this neuronal disorganization will also be seen
within the amygdala and NAcc ROIs. I also hypothesize that SSRI treatment will provide FA
values similar to control participants, indicative of the medication’s protective effects on
glutamatergic excitotoxicity. Building from past literature, I also presume that reduced amygdala
volume will be found in ABCD participants with a clinical level of anxiety, and the volumetric
and diffusion metric differences for this anxious group should also be associated with the
individual’s level of anxiety symptom severity.

Method
Participants
The Adolescent Brain Cognitive Development study is a longitudinal study funded by the
NIH that aims to discover how the brain changes and develops over the period of adolescence
and how neural development is influenced by external factors such as substance use. For the
baseline year, the ABCD study recruited 11,876 participants between 9 and 10 years of age.
These participants were assessed for possible mood, behavioral, and psychiatric disorders using
the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) coupled with the Child
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Behavior Checklist (CBCL), which is “a standardized form that assesses parent-reported
behaviors, problems, and competencies in youth ages 4–18” (Kendall et al., 2007). The
participants were assigned a t-score correlated with their symptom severity for various disorders,
including anxiety, with a t-score of 60 and over indicating a clinical-level disorder. Hence,
baseline participants can be divided into anxiety-disordered (“anxious”) and
non-anxiety-disordered (“controls”) categories. Further, the ABCD study obtained data
concerning all medications its participants were taking at baseline. The anxiety-disordered group
can thus be divided into a medicated subgroup (“SSRI”), indicative of adolescents with clinical
anxiety who were taking any of the five FDA-approved SSRIs at baseline (Citalopram,
Escitalopram, Fluoxetine, Paroxetine, Sertraline), and a NOn-Medicated subgroup (“NOM”). For
this research study, the baseline sample size was narrowed down to participants who underwent
dMRI scanning using Siemens scanners, as these consistently provided the best diffusion MRI
results. Further, subjects were eliminated on the basis of excessive head movement while
undergoing scans to eliminate noisy data; accordingly, 4,055 baseline participants with sufficient
dMRI data were obtained for further analyses. Within these 4,055 participants, 581 fell into the
“anxious” category, 31 into the “SSRI” category, 550 into the “NOM” category, and 3,443 into
the “controls” category.
Procedures
For image preprocessing, the MATLAB mrDiffusion package was utilized. The ABCD
baseline 3D-T1 weighted structural MRI data underwent AC-PC alignment, meaning the
Anterior and Posterior Commissures (major white fiber tracts) and midsagittal plane were
marked as coordinates in the brain to adjust the T1 images for head tilt, and subsequently
transform the T1 images into “AC-PC aligned space” (Leong et al., 2016). The baseline ABCD
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diffusion MRI data was then transformed into this AC-PC aligned space. The AC-PC aligned
data was processed with FreeSurfer software in order to define the amygdala and NAcc brain
regions as Volumes-Of-Interest (VOIs) using a voxel-based “binary mask” that excluded
anatomically inaccurate voxels out of the masked regions. For this study, special emphasis is
placed on the basolateral amygdala as a VOI because the amygdala-to-NAcc connection is based
from the basolateral nucleus of the amygdala (Kamali et al., 2015). For the amygdala to NAcc
connection, MRtrix software was used to perform “constrained spherical deconvolution based
probabilistic tracking” (Leong et al., 2016). The spherical deconvolution tracking method is used
to “estimate the distribution of fibre orientations present within each imaging voxel,” even in
voxels that may have “contributions from differently oriented fibre bundles” (Tournier et al.,
2007). Fiber generation was then accomplished by “seeding a voxel” in either the amygdala or
NAcc VOI and “tracking until the fiber reached the ending VOI” around a million times (Leong
et al., 2016). To obtain a core tract and eliminate outliers, another binary mask, representative of
the anatomically appropriate white matter route from the amygdala to NAcc, was overlaid to
cancel the inaccurately generated fibers that left the mask. The binary mask for the tract was
generated from automated outlier trimming followed by manual adjustment trimming in
MATLAB from an independent study of 216 participants. The generated amygdala to NAcc fiber
tract was then divided into 100 even “nodes” to calculate the mean FA per node by taking an
“average of each fiber’s FA in that node, weighted by the spatial distance of that fiber from the
node’s core fiber” (Leong et al., 2016). This division allows investigation into differences in FA
along the entire trajectory of the white matter tract, which is important when also investigating
neuronal organization within and near associated VOIs.
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Results
To test for significant differences in FA in the right and left BLA VOIs, various
two-sample t-tests were completed for the following groups: anxious vs controls, SSRI vs
controls, NOM vs controls, and NOM vs SSRI. The anxious vs controls t-tests revealed FA is
significantly reduced in the right (t(862) = -1.65, p = 0.05) and left (t(897) = -2.70, p = 0.004)
BLA VOIs for participants with clinical anxiety compared to non-anxious participants. The
t-tests for SSRI vs controls were insignificant for FA differences in the right (t(31) = 1.06, p =
0.30) and left (t(31) = -0.96, p = 0.30) BLA VOIs between the two groups. The NOM vs
controls t-tests showed FA is significantly reduced in both the right (t(804) = -1.96, p = 0.03)
and left (t(825) = -2.62, p = 0.005) BLA regions for participants with a clinical level of anxiety
who are not on an SSRI. The NOM vs SSRI t-tests showed marginal significance for reduced FA
in the right BLA for non-medicated anxious participants compared to medicated participants
(t(33) = -1.50, p = 0.07), but not for the left BLA region (t(37) = -0.09, p = 0.5). To further
elaborate on the significantly reduced FA observed in the right and left BLA for the anxious and
NOM participants, the following linear regressions were run (Figure 1). Results showed that the
3

FA diffusion metric is significantly correlated with BLA volume in 𝑚𝑚 for both hemispheres:
2

2

right (𝑅 = 0.03, F(1, 3785) = 97.69, p < 0.001) and left (𝑅 = 0.03, F(1, 3786) = 122.10, p <
0.001).
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Figure 1. Structural coherence within the BLA is correlated with greater volume (Fractional
2

2

Anistropy; FA; Left: 𝑅 = 0.03, F(1, 3786) = 122.10, p < 0.001; Right: 𝑅 = 0.03, F(1, 3785)
= 97.69, p < 0.001).

Additional t-tests were conducted for the four comparisons to investigate volumetric
3

differences in 𝑚𝑚 for the right and left BLA. The anxious vs controls t-tests results revealed
that BLA volume is significantly reduced in anxiety-disordered participants compared to
non-disordered participants in both the right (t(792) = -2.30, p = 0.01) and left (t(784) = -1.82, p
= 0.03) hemispheres. The SSRI vs controls t-tests indicated reduced BLA volume for
anxiety-disordered participants on an SSRI in the right hemisphere (t(31) = -2.15, p = 0.04), but
not in the left (t(30) = -1.35, p = 0.2). The NOM vs controls t-tests showed that volume is
reduced in the BLA in anxiety-disordered participants who do not take SSRIs in both
hemispheres: right, significantly, (t(737) = -1.95, p = 0.03) and left, marginally, (t(732) = -1.59,
p = 0.06). The NOM vs SSRI t-tests did not indicate significantly reduced BLA volume for
non-medicated anxious participants when compared to medicated: right (t(35) = 1.52, p = 0.9),
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left (t(33) = 0.91, p = 0.8). The previously mentioned BLA statistical tests for FA and volumetric
differences per hemisphere are summarized in Table 1.
Right BLA FA

Right BLA
Volume

Left BLA FA

Left BLA
Volume

Anxious vs
controls

t(862) = -1.65,
p = 0.05*

t(792) = -2.30,
p = 0.01*

t(897) = -2.70,
p = 0.004*

t(784) = -1.82,
p = 0.03*

SSRI vs controls

t(31) = 1.06,
p = 0.3

t(31) = -2.15,
p = 0.04*

t(31) = -0.96,
p = 0.3

t(30) = -1.35,
p = 0.2

NOM vs
controls

t(804) = -1.96,
p = 0.03*

t(737) = -1.95,
p = 0.03*

t(825) = -2.62,
p = 0.005*

t(732) = -1.59,
p = 0.06*

NOM vs SSRI

t(33) = -1.50,
p = 0.07*

t(35) = 1.53,
p = 0.9

t(37) = -0.09,
p = 0.5

t(33) = 0.91,
p = 0.8

Table 1. Summary of BLA-focused statistical tests.
Two-sample t-tests were repeated for the four comparisons to test for a significant
reduction of FA in the right and left NAcc VOIs. The anxious vs controls t-tests were
insignificant for FA differences in the right (t(774) = 1.45, p = 0.2) and left (t(792) = 1.59, p =
0.1) NAcc for anxiety-disordered participants. The SSRI vs controls t-tests were also
insignificant in the right (t(29) = 1.49, p = 0.2) and left (t(29) = 1.30, p = 0.2) NAcc for FA
differences in medicated anxiety-disordered participants compared to non-disordered. FA was
also not found to be significantly altered in the right (t(727) = 1.14, p = 0.3) or left (t(742)=
1.34, p = 0.2) NAcc for anxiety-disordered participants not on SSRIs compared to
non-disordered participants. No significant NAcc FA differences were found in either
hemisphere when comparing the NOM vs SSRI groups: right (t(32) = -1.22, p = 0.2), left (t(32)
= 0.97, p = 0.3).
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The between-group tests for volumetric differences were repeated for the left/right NAcc
(the tests were not run with directionality as NAcc volume changes in anxiety pathophysiology
are more inconspicuous in the literature). The anxious vs controls t-tests showed marginal
significance for an increased volume in anxious participants for the right (t(808) = 1.82, p =
0.07) NAcc, but not for the left (t(802) = 1.47, p = 0.1). SSRI vs controls t-tests did not show
significant volumetric differences in the right (t(30) = 1.00, p = 0.3) or left (t(30) = 0.66, p =
0.5) NAcc, and neither did the NOM vs controls t-tests: right (t(754) = 1.67, p = 0.1), left (t(748)
= 1.38, p = 0.2). The NOM vs SSRI t-tests also did not reveal volumetric differences in the right
(t(33) = -0.55, p = 0.6) or left (t(33) = -0.27, p = 0.8) NAcc for non-medicated anxious
participants versus medicated. The previously mentioned NAcc statistical tests for FA and
volumetric differences per hemisphere are summarized in Table 2.
Left NAcc FA

Left NAcc
Volume

Right NAcc FA

Right NAcc
Volume

Anxious vs
controls

t(792) = 1.59,
p = 0.1

t(802) = 1.47,
p = 0.1

t(774) = 1.45,
p = 0.1

t(808) = 1.82,
p = 0.07*

SSRI vs controls

t(29) = 1.30,
p = 0.2

t(30) = 0.66,
p = 0.5

t(29) = 1.49,
p = 0.1

t(30) = 1.00,
p = 0.3

NOM vs
controls

t(742) = 1.34,
p = 0.2

t(748) = 1.38,
p = 0.2

t(727) = 1.14,
p = 0.3

t(754) = 1.67,
p = 0.1

NOM vs SSRI

t(32) = 0.97,
p = 0.3

t(33) = -0.27,
p = 0.8

t(32) = -1.22,
p = 0.2

t(33) = -0.55,
p = 0.6

Table 2. Summary of NAcc-focused statistical tests.
Two linear regressions were performed to discover if anxiety symptom severity, indicated
by a higher CBCL/DSM-5 derived t-score, is correlated with FA values in the right and left BLA.
For the right BLA, results revealed that higher FA is correlated with a reduced t-score, or less
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anxious symptoms, as seen in Figure 2 (𝑅 = 0.001, F(1, 3859) = 4.66, p = 0.03). For the left
BLA, results showed higher FA is also correlated with reduced t-scores or lower anxiety
2

symptom severity, as seen in Figure 2 (𝑅 = 0.001, F(1, 3875) = 4.74, p = 0.03).

Figure 2. Structural coherence within the BLA is correlated with reduced anxious symptom
2

2

severity (Fractional Anistropy; FA; Left: 𝑅 = 0.001, F(1, 3875) = 4.74, p = 0.03; Right: 𝑅 =
0.001, F(1, 3859) = 4.66, p = 0.03)

Linear regressions were also performed to investigate a possible correlation between
anxiety symptom severity (t-score) and BLA volume. In the right hemisphere (Figure 3), BLA
2

volume is moderately correlated with anxiety symptom severity (𝑅 = 0.001, F(1,3859) = 3.51, p

A Structural Examination: Amyg-NAcc

20
2

= 0.06), but this correlation is insignificant in the left hemisphere as seen in Figure 3 (𝑅 =
0.001, F(1, 3875) = 2.78, p = 0.1).

Figure 3. Greater BLA volume in the right hemisphere is moderately correlated with reduced
2

2

anxious symptom severity (Left: 𝑅 = 0.001, F(1, 3875) = 2.78, p = 0.1; Right: 𝑅 = 0.001,
F(1,3859) = 3.51, p = 0.06)

The following plot (Figure 4) shows the differences in FA across the entire white matter
tract from the BLA to the NAcc for both hemispheres for controls vs anxious participants.
Visually, it appeared possible that a significant FA difference could exist between the grouped
participants for the first 25 nodes (nearest the BLA) for the left hemisphere. To investigate, a
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two-sided t-test was used and revealed that anxiety-disordered participants had significantly
reduced FA values within the range of the first 25 nodes when compared to the control
(non-anxiety) group for the left hemisphere (t(786) = 2.74, p = 0.006).

Figure 4. Anxious participants show reduced structural integrity in the first 25 nodes of the
amyg-NAcc white matter connection in the left hemisphere (Fractional Anistropy; FA; Left:
t(786) = 2.74, p = 0.006).

Discussion
The purpose of this study was to comprehensively characterize two important brain areas
implicated in anxiety disorders, the amygdala and nucleus accumbens, as well as their white
matter connection during a critical period of early adolescence. The consensus in past anxiety
literature of reduced amygdala volume and reduced FA in the major white matter tracts that
connect with limbic structures, and the theories of amygdala hyperactivity and associated
glutamate excitotoxicity as a cause of aberrant neuronal remodeling, led me to hypothesize that
reduced FA will be observed within the amygdala and NAcc ROIs and along their connecting
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white matter tract when compared to adolescents without clinical anxiety. Animal literature
investigating the protective actions of SSRIs also led me to presume that the medicated ABCD
participants with clinical anxiety would show FA values and ROI volumes that more closely
resembled controls than non-medicated anxious participants. Morphometric changes of the NAcc
are underreported in anxiety literature, but as the NAcc is a major glutamatergic output of the
amygdala, I presumed that similar FA and volumetric reductions would be seen in this ROI, as in
the amygdala, in ABCD participants with clinical anxiety.
3

As predicted, significantly reduced FA and reduced volume in 𝑚𝑚 were observed in the
BLA in both hemispheres in ABCD participants with an anxiety disorder when compared to
controls; these findings coincide with aforementioned past research such as the work by Rauch et
al. (2003) and Burkhouse et al. (2020). When looking at the subcategories of the anxious group,
the non-medicated anxious participants showed a decrease in BLA volume (right hemisphere
was significant, left was marginal) and a significant decrease in FA in the BLA of both
hemispheres when compared to controls. While the ABCD participants being treated with SSRIs
showed a reduced right BLA volume, an insignificant difference in BLA FA values was observed
for both hemispheres when compared to controls. This indicates that SSRI administration may
exert a protective role structurally within the amygdala, as the SSRI group FA values more
closely resembled controls. However, the FA differences were not drastic enough to give a
significant difference in either hemisphere when the medicated anxious participants were
compared to the non-medicated anxious participants by t-tests (only marginal significance in the
right BLA was observed). Additionally, SSRI consumption did not appear to confer any
volumetric differences. Although FA is a measure commonly used to decipher white matter tract
integrity, looking at changes in FA within brain regions like the amygdala can provide
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information about the organization of neurons within that region, as well as information about
dendritic remodeling, like dendritic spine formation/reduction, for example. As explained by
Musazzi et al., volumetric changes due to dendritic remodeling are “inferential,” and it was this
statement that prompted my investigation into the correlation between FA and volume of the
BLA; the results indicated a highly significant (p < 0.001) correlation, revealing that lower FA is
associated with a lower BLA volume, and vice versa (2013). Lower FA is associated with
decreased neuronal density, so lower FA within the BLA may be attributed to “decreased
dendritic spine density” (Kubota et al., 2013). Hence, this FA-to-volume correlation likely
provides evidence that dendritic remodeling is an underlying mechanism of volumetric changes
of specific ROIs, in this instance, the BLA. However, dendritic remodeling likely is not the only
underlying mechanism of the observed volumetric changes in the amygdala in participants with
clinical anxiety. The amygdala contains glutamatergic projections between its own nuclei (the
BLA projects to the central nucleus, for example), so decreased FA within the amygdala ROI
could be attributed to diminished integrity of these projecting tracts, and the conjecture of
glutamatergic excitotoxicity within the amygdala provides a mechanism as to how this aberrant
change may occur (Siegle et al., 2006). Thus, this finding provides important evidence of a link
between a structural diffusion metric implicating more macroscopic volumetric changes in the
brain, but further research would be beneficial to undoubtedly confirm the exact mechanisms at
play that result in the major gray matter volumetric differences seen in the amygdala of both
adolescents and adults with clinical anxiety.
Though no significant FA differences were found between groups for the NAcc ROI,
there was a marginally significant increase in right NAcc volume observed in anxious ABCD
participants compared to controls. This is seen in a few anxiety studies such as the Burkhouse et

A Structural Examination: Amyg-NAcc

24

al. study, which reported that in adults anxiety symptom severity is positively correlated with
larger NAcc volumes (2020). Investigating volumetric changes in the NAcc during adolescence
is an area for continued research, and special emphasis should be placed on the later years of
adolescence to see if volumetric changes occur that replicate the prior mentioned adult findings.
This could be done through further analysis of the ABCD participants as this longitudinal trial
progresses and more annual data is released. This opportunity for continued study of NAcc
involvement in anxiety pathophysiology throughout the adolescent period is particularly
interesting because of the increased plasticity of the brain during this stage of human
development. This study utilized baseline 9-10 year olds, and this age may be too early on in the
life course to observe changes in the NAcc in anxious individuals that could possibly occur from
amygdala hyperresponsivity and irregular tract integrity.
Investigation of FA differences along the white matter amygdala-to-NAcc tract were
focused on the first 25, middle 50, and final 25 nodes. Within the first 25 nodes of the left
hemisphere tract, a significant reduction in FA was observed for ABCD participants with a
clinical level of anxiety. Though this FA reduction coincides with the findings within the
amygdala, and these first 25 nodes are nearest to the BLA, some important limitations of
generating the white matter tract should be discussed. Constrained spherical deconvolution based
probabilistic tracking is an error-prone process; oftentimes more than one fiber tract will be
automatically generated, or fibers that are anatomically impossible may be generated. Automated
outlier trimming, masking, and manual fiber trimming are ways to fix or delete these erroneous
fibers; but unfortunately, with a sample size as large as the ABCD study, manual fiber trimming
is simply not feasible, so there is the possibility of some fiber generation errors going unnoticed.
Despite this limitation, dMRI still provides crucial information about tract integrity and
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myelination that is important to consider when investigating anxiety pathophysiology, as
diminished axonal integrity/myelination is “suggested to lead to neuronal deficits such as
alterations in synaptic function” (Kubota et al., 2013). Thus, reduced FA along the amyg-NAcc
tract indicates the possibility for future dysregulation from the amygdala neuron projections that
synapse within the nucleus accumbens. Future research that utilizes an older sample size could
investigate this possible effect as the 9-10 year-olds of the baseline year of the ABCD study may
not have experienced an anxiety disorder prolonged enough to generate structural changes along
an entire white matter tract, assuming the white matter tract differences are the result of a
cognitive process like neurotransmitter toxicity versus an inherent genetic predisposition.
The study by Burkhouse et al. that reported reduced amygdala volume in patients with
anxiety also found that symptom severity was inversely correlated with left amygdala volume;
however, the linear regressions I performed to investigate an association of BLA volume with
symptom severity did not replicate this finding (2020). A white matter study by Wang et al.
(2016) found a significant inverse relationship between UF and cingulum FA values and
symptom severity, while another white matter study of the amyg-PFC connection by Kim &
Whalen (2009) also reported a significant inverse relationship between tract FA and anxiety
severity. The linear regressions I ran for both hemispheres to investigate the FA association with
anxiety symptom severity also found that FA in the BLA is significantly, inversely correlated
with anxious symptoms when restricting at an FA value of 0.4. As seen in Figure 2, participants
within the 0.25-0.4 FA metric range appear to skew this correlation; yet, it seems unreasonable to
restrict the FA metric further as this would exclude numerous participants rather than a few
extraneous outliers. Moreover, FA reduction amongst white matter connections, especially those
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that link limbic structures, is a common theme in anxiety literature, as well as associated
increased symptom severity.
Another interesting area of future research is the protective effects of SSRIs at the
structural level in individuals with an anxiety disorder; an investigation into this effect would be
best represented longitudinally, and the ABCD study will provide this opportunity for analysis in
the future. Future research could use the dMRI data released by the ABCD study to follow
SSRI-taking participants throughout adolescence and compare these individuals to
non-medicated participants that remain at a clinical level of anxiety throughout adolescence to
investigate how this intervention mediates neuronal structural changes. Future research that
compares anxious adolescents who take SSRIs to those that receive other interventions like
cognitive behavioral therapy would also be extremely beneficial to identify the most effective
treatment option that may reduce the prominence of anxiety in the adolescent population. Within
the almost 12,000 participants of the baseline year, 14.7% of these young adolescents were rated
as having a clinical level of anxiety. This is an alarming percentage, so effective treatment
interventions need to be identified and implemented early in the life course in hopes to reduce
the prominence of anxiety in future society. Though the ABCD study’s large sample size brought
about difficulty in image processing and tractography, the large sample size makes this study
more applicable to the general public. Additionally, although the ABCD study did not partition
the adolescents based on a specific anxiety disorder, and rather used a generalized rating/score,
this also makes the study more applicable to society due to the prominence of comorbidity of
either multiple anxiety disorders or anxiety and depression. Although this study only analyzed
baseline data, the ABCD study will provide the opportunity for continued anxiety research due to
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its longitudinal nature and provides the opportunity to further investigate cognitive changes that
occur in adolescents with clinical anxiety over time.
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